| [1] |
|
| [2] |
WAGNER KH, SHIELS RG, LANG CA, et al. Diagnostic criteria and contributors to Gilbert's syndrome[J]. Crit Rev Clin Lab Sci, 2018, 55(2): 129-139. DOI: 10.1080/10408363.2018.1428526. |
| [3] |
|
| [4] |
KANG LL, LIU ZL, ZHANG HD. Gilbert's syndrome coexisting with hereditary spherocytosis might not be rare: Six case reports[J]. World J Clin Cases, 2020, 8(10): 2001-2008. DOI: 10.12998/wjcc.v8.i10.2001. |
| [5] |
|
| [6] |
MARUO Y, NAKAHARA S, YANAGI T, et al. Genotype of UGT1A1 and phenotype correlation between Crigler-Najjar syndrome type Ⅱ and Gilbert syndrome[J]. J Gastroenterol Hepatol, 2016, 31(2): 403-408. DOI: 10.1111/jgh.13071. |
| [7] |
GU GX, ZONG ZP, ZHOU T, et al. Living related donor liver transplantation for infant with Crigler-Najjar syndrome type Ⅰ: A report of one case and literature review[J]. Ogran Transplant, 2020, 11(4): 471-476. DOI: 10.3969/j.issn.1674-7445.2020.04.008. |
| [8] |
BLACK M, BILLING BH. Hepatic bilirubin udp-glucuronyl transferase activity in liver disease and Gilbert's syndrome[J]. N Engl J Med, 1969, 280(23): 1266-1271. DOI: 10.1056/NEJM196906052802303. |
| [9] |
BARCELLINI W, FATTIZZO B. Clinical applications of hemolytic markers in the differential diagnosis and management of hemolytic anemia[J]. Dis Markers, 2015, 2015: 635670. DOI: 10.1155/2015/635670. |
| [10] |
ARIAS IM, GARTNER LM, COHEN M, et al. Chronic nonhemolytic unconjugated hyperbilirubinemia with glucuronyl transferase deficiency. Clinical, biochemical, pharmacologic and genetic evidence for heterogeneity[J]. Am J Med, 1969, 47(3): 395-409. DOI: 10.1016/0002-9343(69)90224-1. |
| [11] |
ZHANG M, WANG H, HUANG Y, et al. Compound heterozygous UGT1A1*28 and UGT1A1*6 or single homozygous UGT1A1*28 are major genotypes associated with Gilbert's syndrome in Chinese Han people[J]. Gene, 2021, 781: 145526. DOI: 10.1016/j.gene.2021.145526. |
DownLoad:
